Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?

Sullivan LE, Chawarski M, O'Connor PG, Schottenfeld RS, Fiellin DA.

Drug Alcohol Depend. 2005 Jul;79(1):113-6.

PMID:
15943950
2.

Opioid dependence treatment, including buprenorphine/naloxone.

Raisch DW, Fye CL, Boardman KD, Sather MR.

Ann Pharmacother. 2002 Feb;36(2):312-21. Review.

PMID:
11847954
3.

The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence.

Simoens S, Matheson C, Bond C, Inkster K, Ludbrook A.

Br J Gen Pract. 2005 Feb;55(511):139-46. Review.

4.

Buprenorphine for the treatment of opioid dependence.

Boothby LA, Doering PL.

Am J Health Syst Pharm. 2007 Feb 1;64(3):266-72. Review.

PMID:
17244875
5.

Buprenorphine for office-based practice: consensus conference overview.

Kosten TR, Fiellin DA; U.S. National Buprenorphine Implementation Program.

Am J Addict. 2004;13 Suppl 1:S1-7. Review.

PMID:
15204671
6.

Buprenorphine for office-based treatment of patients with opioid addiction.

Manlandro JJ Jr.

J Am Osteopath Assoc. 2005 Jun;105(6 Suppl 3):S8-13. Review.

PMID:
16118361
7.

Bupreorphine:a new pharmacotherapy for opioid addictions treatment.

Stock C, Shum JH.

J Pain Palliat Care Pharmacother. 2004;18(3):35-54. Review.

PMID:
15364630
8.

Managing opioid addiction with buprenorphine.

Donaher PA, Welsh C.

Am Fam Physician. 2006 May 1;73(9):1573-8. Review.

9.

From opioid maintenance to abstinence: a literature review.

Kornør H, Waal H.

Drug Alcohol Rev. 2005 May;24(3):267-74. Review.

PMID:
16096130
10.

Consensus statement on office-based treatment of opioid dependence using buprenorphine.

Fiellin DA, Kleber H, Trumble-Hejduk JG, McLellan AT, Kosten TR.

J Subst Abuse Treat. 2004 Sep;27(2):153-9. Review.

PMID:
15450648
11.
12.

History and current status of opioid maintenance treatments: blending conference session.

Kreek MJ, Vocci FJ.

J Subst Abuse Treat. 2002 Sep;23(2):93-105. Review.

PMID:
12220607
13.

Opioid dependence: rationale for and efficacy of existing and new treatments.

Fiellin DA, Friedland GH, Gourevitch MN.

Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S173-7. Review.

14.

Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence.

Orman JS, Keating GM.

Drugs. 2009;69(5):577-607. doi: 10.2165/00003495-200969050-00006. Review.

PMID:
19368419
15.

Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence.

Sullivan LE, Fiellin DA.

Clin Infect Dis. 2005 Sep 15;41(6):891-6. Epub 2005 Aug 10. Review.

16.

Office-based buprenorphine treatment for opioid-dependent patients.

McCance-Katz EF.

Harv Rev Psychiatry. 2004 Nov-Dec;12(6):321-38. Review.

PMID:
15764468
17.

The medical management of opioid dependence in HIV primary care settings.

Lum PJ, Tulsky JP.

Curr HIV/AIDS Rep. 2006 Nov;3(4):195-204. Review.

PMID:
17089480
18.

Narrative review: buprenorphine for opioid-dependent patients in office practice.

Sullivan LE, Fiellin DA.

Ann Intern Med. 2008 May 6;148(9):662-70. Review.

19.

Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.

Vigezzi P, Guglielmino L, Marzorati P, Silenzio R, De Chiara M, Corrado F, Cocchi L, Cozzolino E.

J Subst Abuse Treat. 2006 Jul;31(1):3-7. Review.

PMID:
16814005
20.

Using buprenorphine for outpatient opioid detoxification.

Manlandro JJ Jr.

J Am Osteopath Assoc. 2007 Sep;107(9 Suppl 5):ES11-6. Review.

PMID:
17908825
Items per page

Supplemental Content

Write to the Help Desk